CLS receives second order from the National Institutes of Health Clinical Center in the US
Lund, Sweden April 9, 2024 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the company”) today announced that it has received its second order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System accessories.The order of single-use sterile instruments includes introducers, temperature probes, and unique, non-cooled laser applicators that will be used to assess the clinical utility of CLS’s TRANBERG Thermal Therapy System towards MRI/Ultrasound fusion-guided focal laser ablation (FLA) of prostate tissue and prostate cancer in male